Use of topical lithium succinate for seborrhoeic dermatitis.
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D002986:Clinical Trials as Topic; D012628:Dermatitis, Seborrheic / Q000188:drug therapy*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008094:Lithium / Q000008:administration & dosage* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009942:Organometallic Compounds; D013386:Succinates / Q000008:administration & dosage* / Q000627:therapeutic use
D009942:Organometallic Compounds; D013386:Succinates; D008094:Lithium; C038377:lithium succinate